Research ArticleClinical Studies

Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma

KYOSUKE NISHIO, KENSUKE HIROSUNA, TAIZO UCHIMOTO, HEIMA NIIGAWA, SHO KAKUMAE, TAISUKE JO, HIROFUMI MORINAKA, WATARU FUKUOKAYA, ATSUHIKO YOSHIZAWA, MASANOBU SARUTA, MAMORU HASHIMOTO, TAKAFUMI MINAMI, YUTAKA YAMAMOTO, MORITOSHI SAKAMOTO, KAZUKI NISHIMURA, RYOICHI MAENOSONO, TAKUYA TSUJINO, YUKI YOSHIKAWA, FUMIHIKO URABE, KEIICHIRO MORI, TAKAFUMI YANAGISAWA, SHUNSUKE TSUDUKI, KIYOSHI TAKAHARA, TERUO INAMOTO, KAZUTOSHI FUJITA, TAKAHIRO KIMURA, HARUHITO AZUMA and KAZUMASA KOMURA
Anticancer Research October 2025, 45 (10) 4575-4583; DOI: https://doi.org/10.21873/anticanres.17803

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma
KYOSUKE NISHIO, KENSUKE HIROSUNA, TAIZO UCHIMOTO, HEIMA NIIGAWA, SHO KAKUMAE, TAISUKE JO, HIROFUMI MORINAKA, WATARU FUKUOKAYA, ATSUHIKO YOSHIZAWA, MASANOBU SARUTA, MAMORU HASHIMOTO, TAKAFUMI MINAMI, YUTAKA YAMAMOTO, MORITOSHI SAKAMOTO, KAZUKI NISHIMURA, RYOICHI MAENOSONO, TAKUYA TSUJINO, YUKI YOSHIKAWA, FUMIHIKO URABE, KEIICHIRO MORI, TAKAFUMI YANAGISAWA, SHUNSUKE TSUDUKI, KIYOSHI TAKAHARA, TERUO INAMOTO, KAZUTOSHI FUJITA, TAKAHIRO KIMURA, HARUHITO AZUMA, KAZUMASA KOMURA
Anticancer Research Oct 2025, 45 (10) 4575-4583; DOI: 10.21873/anticanres.17803
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords